Cababaro, Margie A.
HRN: 25-34-39 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
MUPIROCIN 2%, 15G (TUBE)
06/23/2024
06/29/2024
SKIN
Apply On Affected Area
Apply OD
Sp LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes